NSC-658931

N/A

Report date: 2024/01/10 15:11:29
NME

Base Information

Drug NameNSC-658931
Drug Alias NameLMB-7B3(Fv) PE-38NSC-658931
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLewis-Y antigen antagonists
TargetsLewis-Y antigen
Therapy Area/IndicationsCNS Embryonal TumorNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke UniversityNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsCNS Embryonal TumorNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A